Search Prime Grants

UM1TR004927

Cooperative Agreement

Overview

Grant Description
Institute for Clinical and Translational Science - Our goal is to build the UCI CTSA hub as an innovative, nimble, and dynamic virtual laboratory that can implement NCATS’s bold vision for translational science.

Fueled by unprecedented growth in UCI’s research portfolio, new inpatient and outpatient capacity, and robust collaboration with community stakeholders, our hub is positioned to profoundly impact the science of translation and public health in our region and beyond.

Two formative and synergistic themes guide our hub’s strategy for the next funding cycle.

The first, “From Lab to Life,” was developed by our community partners at the inaugural CTSA funding in 2010 and reflects the seminal and ongoing NCATS’s focus on nurturing the kernels of translational science that can be found in virtually all clinical research.

We will catalyze a wide range of basic and applied innovations enabled by unique UCI and community talent, such as:

1) Transforming clinical trials in rare diseases,

2) Reimagining cell-based diagnostic and therapeutic technologies for a broad spectrum of health conditions, and

3) Reconceptualizing the practice of neurorehabilitation through AI-based mechanistic use of haptic robotics.

Our second theme, “From Hub to Health,” embraces NCATS’s and our hub’s burgeoning focus and expertise on dissemination and implementation, on diversity and inclusive excellence, and on harnessing the science of translation to mitigate health disparities and inequities.

In preparing “From Hub to Health” objectives, we worked closely with the Orange County Health Care Agency (OCHCA), our county public health department, which serves more than 3.2M people, a diverse population and a microcosm of healthcare needs, inequities, and disparities seen across the U.S.

The Healthy School Restart Program pioneered data-driven policy guidance for community schools during the pandemic and blossomed into a formal hub-OCHCA collaboration.

“From Hub to Health” projects for the next funding cycle are wide ranging and include:

1) The request from OCHCA for the hub to serve as the translational science collaborator for the community-wide OC System of Care Think Tank to reduce health care disparities and inequities in our region,

2) Expanding our hub medical student research program to achieve unprecedented gains in URM participation in translational science,

3) Leading a novel, nationally funded program to train a community-based workforce in population-health informatics and data science, and

4) Re-envisioning design of investigator-initiated clinical trials by developing, demonstrating, and disseminating our program of quality-by-design studios.

Our partnerships with UCI-affiliated Children’s Hospital of Orange County and the Long Beach Veterans Administration ensure that these essential populations will be well represented in all hub activities.

The hub will support these projects by careful allocation of resource modules, training opportunities, and continuous quality improvement with a vigorous application of the translational science benefits model.

In sum, we are positioned to promote “more treatments for all people more quickly,” the translational science goal that has guided our hub since 2010.
Funding Goals
NOT APPLICABLE
Place of Performance
Irvine, California 926173058 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 99% from $4,099,887 to $8,164,968.
Irvine University Of California was awarded UCI CTSA Hub: Advancing Translational Science for Public Health Impact Cooperative Agreement UM1TR004927 worth $8,164,968 from National Center for Advancing Translational Sciences in July 2024 with work to be completed primarily in Irvine California United States. The grant has a duration of 7 years and was awarded through assistance program 93.350 National Center for Advancing Translational Sciences. The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).

Status
(Ongoing)

Last Modified 7/25/25

Period of Performance
7/16/24
Start Date
6/30/31
End Date
19.0% Complete

Funding Split
$8.2M
Federal Obligation
$0.0
Non-Federal Obligation
$8.2M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to UM1TR004927

Subgrant Awards

Disclosed subgrants for UM1TR004927

Transaction History

Modifications to UM1TR004927

Additional Detail

Award ID FAIN
UM1TR004927
SAI Number
UM1TR004927-974615129
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
MJC5FCYQTPE6
Awardee CAGE
0VWL0
Performance District
CA-47
Senators
Dianne Feinstein
Alejandro Padilla
Modified: 7/25/25